GreenLight is focused on bringing novel cannabinoid medicines to market for the treatment of conditions such as multiple sclerosis, glaucoma, arthritis, epilepsy and cancer

Canadian-listed investment group SOL Global is to acquire a 25 per cent stake in Irish medical cannabis company GreenLight Medicines in a €1.8 million(...)

Photograph: Getty Images

Plans to develop new cannabis-based treatments for some of the most common forms of epilepsy have been announced by a team of Irish scientists. The i(...)

UCD’s Dr Keith Murphy  with Dr James Linden, founder of GreenLight Medicines. Photograph: Peter Houlihan / Fennell Photography

Pharmaceutical start-up GreenLight Medicines has secured €500,000 in funding as it seeks to develop “breakthrough medicines” using cannabis extracts. (...)